£515.00

It has never been this cheap. We have no record of a lower price.

£515 today · cheaper than every other day in the last 3 months

Natural Killer Cell Therapeutics Outlook in India 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 32 days · 32 data points (no recent data)

Historical
Generating forecast…
£515.00 £489.25 £499.55 £509.85 £520.15 £530.45 £540.75 03 August 2026 10 August 2026 18 August 2026 26 August 2026 03 September 2026
View at Amazon ↗

Price data last checked 59 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 32 days • 1 price levels

Days at Price
32 days 0 8 16 24 32 £515 Days at Price

Price Analysis

Most common price: £515 (32 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 32 days

Description

This comprehensive market study provides a detailed outlook for natural killer cell therapeutics in India from 2023 to 2028. The report focuses on latent demand, providing potential industry earnings (P.I.E.) estimates in millions of U.S. dollars. By analyzing data across states, union territories, and over 4,900 cities, this research offers a granular view of the market landscape. Users can access comparative benchmarks that show the percent share each city holds within its respective state or union territory, as well as its share of the total Indian market. This statistical approach is designed to assist professionals in developing effective distribution and sales force strategies. The data provides the necessary economic insights to gauge specific city performance against others throughout the country.

Key Features

Provides latent demand outlook for natural killer cell therapeutics in India from 2023 to 2028.

Includes potential industry earnings (P.I.E.) estimates in millions of U.S. dollars.

Covers detailed market data across over 4,900 cities, states, and union territories in India.

Offers comparative benchmarks by reporting the percent share of each city relative to its state and the national market.

Supports the development of distribution and sales force strategies through detailed statistical analysis.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
14 September 2022
Listed Since
29 September 2022

Similar Products You Might Like

The 2023-2028 Outlook for Natural Killer Cell Therapeutics in China
99% match

The 2023-2028 Outlook for Natural Killer Cell Therapeutics in China

£495.00 18 Aug 2026
The 2023-2028 Outlook for Natural Killer Cell Therapeutics in Japan
99% match

The 2023-2028 Outlook for Natural Killer Cell Therapeutics in Japan

£495.00 24 Aug 2026
The 2023 Report on Natural Killer Cell Therapeutics: World Market Segmentation by City
99% match

The 2023 Report on Natural Killer Cell Therapeutics: World Market Segmentation by City

£795.00 19 Aug 2026
Natural Killer Cell Therapeutics US Zip Code Outlook 2023-2028
98% match

Natural Killer Cell Therapeutics US Zip Code Outlook 2023-2028

£490.00 21 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 30 Sep 2026
Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028
97% match

Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028

£515.00 22 Aug 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States

£520.00 22 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in India
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in India

£515.00 21 Aug 2026
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£995.00 15 Aug 2026
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£790.00 01 Oct 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China
97% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China

£595.00 27 Oct 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States

£520.00 21 Aug 2026
The 2025-2030 World Outlook for Immune-Oncology Treatments
97% match

The 2025-2030 World Outlook for Immune-Oncology Treatments

£790.00 25 Aug 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
97% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£595.00 19 Aug 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in India
97% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in India

£515.00 22 Aug 2026
The 2016 Report on Non-Small Cell Lung Cancer Therapeutics: World Market Segmentation by City
97% match

The 2016 Report on Non-Small Cell Lung Cancer Therapeutics: World Market Segmentation by City

£995.00 24 Oct 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in the United States
97% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in the United States

£520.00 21 Aug 2026
Natural Killer (NK) Cells: Methods and Protocols: 2463 (Methods in Molecular Biology, 2463)
97% match

Natural Killer (NK) Cells: Methods and Protocols: 2463 (Methods in Molecular Biology, 2463)

Humana

£112.77 30 Sep 2026
Natural Killer (NK) Cells: Methods and Protocols: 2463 (Methods in Molecular Biology, 2463)
97% match

Natural Killer (NK) Cells: Methods and Protocols: 2463 (Methods in Molecular Biology, 2463)

Humana

£141.80 25 Sep 2026
The 2025-2030 World Outlook for T-Cell Therapies
97% match

The 2025-2030 World Outlook for T-Cell Therapies

£790.00 27 Aug 2026
The 2021-2026 World Outlook for Silent Cancer Therapeutics
97% match

The 2021-2026 World Outlook for Silent Cancer Therapeutics

£795.00 31 Oct 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in India
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in India

£515.00 15 Aug 2026
The 2023-2028 Outlook for Digital Therapeutics Sales in India
97% match

The 2023-2028 Outlook for Digital Therapeutics Sales in India

£515.00 25 Aug 2026